Ping
How much did Novo Nordisk have to spend on this failed trial?
Now, if it had succeeded, how much MORE do they have to spend to get it approved and produced for Alzheimer’s patients?
Finally how much would it cost for a patient so that companies like Novo Nordisk can recoup their cost?
Weird. I know there’s a theory that Alzheimer’s might be diabetes type 3 but you’d think other types of diabetes treatments would’ve already been tried and failed. I wonder if they thought there was some other aspect that it would impact.
Off label uses for drugs are common. Sometimes they develop spontaneously as people using them for X report apparent side benefits. Anecdotal reports pile up, an informal market develops, and the researchers move in, if only because they have to get it approved for Y to eventually get something eligible for insurance coverage.
How did the researchers get interested in this case? Anecdotal reports (which apparently aren’t standing up to scrutiny)? Or some analytical, research driven chain of exploring a possibly promising class of drugs?
If there’s a research driven lead, one reason for looking at something like Ozempic is simply that the research on side effects is already developed. And the production base is preexisting. That’s a big shortcut.
Better off trying coconut oil and dmso, from what I have read.